Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (31-40 of 416) with videos related to

Pageof 42
Sort By:
Frontiers in Oncology|October 25, 2021
The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the LiteratureGiovanna Garufi, Luisa Carbognin, Armando Orlandi, et al.
Expert Opinion on Drug Safety|April 2, 2014
Targeting the epidermal growth factor receptor in solid tumors: focus on safetyEleonora Lucchini, Sara Pilotto, Elisa Spada, et al.
Annals of Translational Medicine|February 7, 2017
MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapySara Pilotto, Anastasios Gkountakos, Luisa Carbognin, et al.
Critical Reviews in Oncology/Hematology|January 19, 2025
Real-world evidence in extensive disease small cell lung cancer: The missing piece of the puzzlePaola Damiano, Alessio Stefani, Alice Avancini, et al.
Reviews on Recent Clinical Trials|September 11, 2008
The role of cetuximab and other epidermal growth factor receptor monoclonal antibodies in the treatment of advanced non-small cell lung cancerAntonio Rossi, Emilio Bria, Paolo Maione, et al.
Expert Review of Anticancer Therapy|August 26, 2010
Early recurrence risk: aromatase inhibitors versus tamoxifenEmilio Bria, Paolo Carlini, Federica Cuppone, et al.
Therapeutic Advances in Medical Oncology|June 9, 2021
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patientsAnastasios Gkountakos, Pietro Delfino, Rita T Lawlor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?Emilio Bria, Massimo Di Maio, Federica Cuppone, et al.
Translational Lung Cancer Research|March 10, 2016
Cellular and molecular biology of small cell lung cancer: an overviewNiki Karachaliou, Sara Pilotto, Chiara Lazzari, et al.
European Journal of Cancer Care|December 23, 2016
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian surveyDomenica Lorusso, Emilio Bria, Anna Costantini, et al.
Pageof 42

Showing results (31-40 of 416) with videos related to

Sort By:
Pageof 42
Frontiers in Oncology|October 25, 2021
The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the LiteratureGiovanna Garufi, Luisa Carbognin, Armando Orlandi, et al.
Expert Opinion on Drug Safety|April 2, 2014
Targeting the epidermal growth factor receptor in solid tumors: focus on safetyEleonora Lucchini, Sara Pilotto, Elisa Spada, et al.
Annals of Translational Medicine|February 7, 2017
MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapySara Pilotto, Anastasios Gkountakos, Luisa Carbognin, et al.
Critical Reviews in Oncology/Hematology|January 19, 2025
Real-world evidence in extensive disease small cell lung cancer: The missing piece of the puzzlePaola Damiano, Alessio Stefani, Alice Avancini, et al.
Reviews on Recent Clinical Trials|September 11, 2008
The role of cetuximab and other epidermal growth factor receptor monoclonal antibodies in the treatment of advanced non-small cell lung cancerAntonio Rossi, Emilio Bria, Paolo Maione, et al.
Expert Review of Anticancer Therapy|August 26, 2010
Early recurrence risk: aromatase inhibitors versus tamoxifenEmilio Bria, Paolo Carlini, Federica Cuppone, et al.
Therapeutic Advances in Medical Oncology|June 9, 2021
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patientsAnastasios Gkountakos, Pietro Delfino, Rita T Lawlor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?Emilio Bria, Massimo Di Maio, Federica Cuppone, et al.
Translational Lung Cancer Research|March 10, 2016
Cellular and molecular biology of small cell lung cancer: an overviewNiki Karachaliou, Sara Pilotto, Chiara Lazzari, et al.
European Journal of Cancer Care|December 23, 2016
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian surveyDomenica Lorusso, Emilio Bria, Anna Costantini, et al.
Pageof 42